Dimensional Fund Advisors LP Raises Stock Holdings in The Clorox Company (NYSE:CLX)

Dimensional Fund Advisors LP increased its stake in shares of The Clorox Company (NYSE:CLX) by 4.2% in the fourth quarter, HoldingsChannel reports. The firm owned 677,406 shares of the company’s stock after buying an additional 27,225 shares during the quarter. Dimensional Fund Advisors LP’s holdings in The Clorox were worth $136,779,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Marshall Wace North America L.P. acquired a new stake in shares of The Clorox during the 1st quarter worth about $65,000. Eudaimonia Partners LLC lifted its stake in shares of The Clorox by 1,569.3% during the third quarter. Eudaimonia Partners LLC now owns 105,000 shares of the company’s stock valued at $77,000 after buying an additional 98,710 shares during the period. Advisory Alpha LLC acquired a new stake in The Clorox during the third quarter worth approximately $46,000. Lombard Odier Asset Management Europe Ltd purchased a new stake in The Clorox in the 3rd quarter worth approximately $255,000. Finally, Cubist Systematic Strategies LLC raised its holdings in The Clorox by 71.1% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 109,621 shares of the company’s stock valued at $23,039,000 after acquiring an additional 45,555 shares during the last quarter. 81.73% of the stock is owned by hedge funds and other institutional investors.

In other news, CFO Kevin B. Jacobsen sold 35,176 shares of The Clorox stock in a transaction that occurred on Monday, January 25th. The shares were sold at an average price of $215.00, for a total transaction of $7,562,840.00. Following the sale, the chief financial officer now owns 26,491 shares in the company, valued at $5,695,565. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Eric H. Reynolds sold 3,147 shares of the business’s stock in a transaction on Monday, January 25th. The stock was sold at an average price of $214.07, for a total transaction of $673,678.29. Following the transaction, the chief operating officer now directly owns 16,997 shares in the company, valued at $3,638,547.79. The disclosure for this sale can be found here. 1.09% of the stock is currently owned by company insiders.

A number of brokerages have recently commented on CLX. Sanford C. Bernstein started coverage on The Clorox in a research report on Tuesday, January 19th. They issued a “market perform” rating and a $206.00 price objective for the company. Bank of America decreased their price target on The Clorox from $245.00 to $235.00 and set a “neutral” rating on the stock in a research note on Friday, January 22nd. Wells Fargo & Company reaffirmed a “buy” rating and set a $240.00 price objective on shares of The Clorox in a research note on Wednesday, February 10th. DA Davidson reissued a “neutral” rating and issued a $189.00 target price on shares of The Clorox in a research report on Wednesday, March 24th. Finally, Smith Barney Citigroup raised shares of The Clorox from a “neutral” rating to a “buy” rating and upped their price target for the stock from $238.00 to $249.00 in a research report on Monday, December 14th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $216.65.

The Clorox stock opened at $194.00 on Thursday. The firm has a fifty day moving average of $187.51 and a 200-day moving average of $200.27. The Clorox Company has a 52-week low of $176.73 and a 52-week high of $239.87. The company has a quick ratio of 1.06, a current ratio of 1.41 and a debt-to-equity ratio of 2.12. The firm has a market capitalization of $24.40 billion, a P/E ratio of 21.60, a PEG ratio of 3.39 and a beta of 0.21.

The Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, February 3rd. The company reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.78 by $0.25. The Clorox had a net margin of 16.14% and a return on equity of 132.72%. The firm had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.75 billion. During the same period in the prior year, the company earned $1.46 EPS. The firm’s revenue was up 27.1% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 8.03 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, May 7th. Stockholders of record on Wednesday, April 21st will be given a $1.11 dividend. This represents a $4.44 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Tuesday, April 20th. The Clorox’s payout ratio is 60.33%.

The Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Read More: How to Invest in the Dividend Aristocrat Index

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.